Loading
A phase 3 trial of epirubicin, cyclophosphamide, paclitaxel / nab-paclitaxel, carboplatin and other drugs in triple-negative breast cancer, run by Lund University Hospital, active but no longer recruiting.
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC is a phase 3, randomised interventional study registered as NCT04335669 by Lund University Hospital, with a registry enrolment figure of 325 participants, started 2019-12-20 and due to reach its primary completion in 2035-09. Interventions recorded: epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumab; epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumab. Conditions listed: Breast Cancer; Triple Negative Breast Neoplasms. Sites: Denmark, Sweden. No results are recorded here; the registry entry is the source.
Shares Epirubicin, Cyclophosphamide, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Epirubicin, Cyclophosphamide, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Cyclophosphamide, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents and the tag tnbc-deep-dive.
Shares Epirubicin, Capecitabine, Cyclophosphamide, Early triple-negative breast cancer and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Paclitaxel / nab-paclitaxel and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Paclitaxel / nab-paclitaxel and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Paclitaxel / nab-paclitaxel and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Paclitaxel / nab-paclitaxel and the tag tnbc-deep-dive.